MedPath

Flurbiprofen

Generic Name
Flurbiprofen
Drug Type
Small Molecule
Chemical Formula
C15H13FO2
CAS Number
5104-49-4
Unique Ingredient Identifier
5GRO578KLP
Background

Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen.

Indication

Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis.

Associated Conditions
Ankylosing Spondylitis (AS), Back Pain, Acute, Chronic Back Pain, Menstrual Distress (Dysmenorrhea), Muscle Spasms, Non-Articular Rheumatic Muscle Spasms, Osteoarthritis (OA), Pain, Pain, Inflammatory, Post Traumatic Pain, Postoperative pain, Rheumatoid Arthritis, Spinal pain

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Phase 2
Recruiting
Conditions
Patient-controlled Analgesia
NSAIDs
Opioid
Esophageal Cancer
Perioperative Analgesia
Interventions
First Posted Date
2022-08-17
Last Posted Date
2025-03-20
Lead Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Target Recruit Count
102
Registration Number
NCT05504265
Locations
🇨🇳

Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2022-02-24
Last Posted Date
2022-05-04
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
Target Recruit Count
22
Registration Number
NCT05254548
Locations
🇩🇪

CRS Clinical Research Services Berlin GmbH, Berlin, Germany

Chinese Tuina Therapy for Treatment of Chronic Nonspecific Low Back Pain

Not Applicable
Conditions
Chronic Nonspecific Low Back Pain
Interventions
Behavioral: Chinese Tuina therapy
First Posted Date
2021-07-26
Last Posted Date
2022-01-04
Lead Sponsor
Beijing University of Chinese Medicine
Target Recruit Count
90
Registration Number
NCT04976790
Locations
🇨🇳

Beiing university of Chinese medicine Dongzhimen Hospital, Beijing, Beijing, China

Oro-tracheal Intubation: Flurbiprofen Subglottic Instillation to Prevent Laryngeal Inflammation

Phase 2
Conditions
D010612
Interventions
Drug: saline solution
First Posted Date
2021-01-14
Last Posted Date
2021-01-14
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
70
Registration Number
NCT04708964

Bioequivalence of Flurbiprofen Lozenge vs Strepfen

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2020-12-17
Last Posted Date
2020-12-17
Lead Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Target Recruit Count
24
Registration Number
NCT04670601
Locations
🇨🇭

CROSS Research S.A., Phase I Unit, Arzo, Switzerland

Drug-drug Interaction Study of KL1333 in Healthy Subjects

First Posted Date
2020-11-25
Last Posted Date
2021-10-20
Lead Sponsor
Abliva AB
Target Recruit Count
14
Registration Number
NCT04643249
Locations
🇬🇧

Volunteer recruitment center Covance Leeds Covance Leeds, Leeds, United Kingdom

Effect of Preemptive Analgesia With Flurbiprofen Axetil on Perioperative Sleep Quality and Postoperative Pain in Patients Undergoing Sevoflurane Inhalation.

Phase 1
Conditions
Flurbiprofen Axetil
Preemptive Analgesia
Postoperative Pain
Perioperative Sleep Quality
Postoperative Inflammatory Markers
Interventions
First Posted Date
2020-11-02
Last Posted Date
2022-01-10
Lead Sponsor
Beijing Friendship Hospital
Target Recruit Count
100
Registration Number
NCT04611763
Locations
🇨🇳

beijing friendship hospital of Capital Medical university, Beijing, China

Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients

Phase 4
Completed
Conditions
Remimazolam
Sedation Complication
Midazolam
Interventions
First Posted Date
2020-10-26
Last Posted Date
2022-03-15
Lead Sponsor
Peking University
Target Recruit Count
81
Registration Number
NCT04602845
Locations
🇨🇳

Peking University Hospital of Stomatology, Beijing, Beijing, China

🇨🇳

Zijian Guo, Haidian, Beijing, China

Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

First Posted Date
2020-06-11
Last Posted Date
2024-01-05
Lead Sponsor
ViiV Healthcare
Target Recruit Count
20
Registration Number
NCT04425902
Locations
🇺🇸

GSK Investigational Site, Las Vegas, Nevada, United States

Evaluation of the Effects of Different Analgesics on Pericoronitis Pain and Quality of Life

Phase 4
Completed
Conditions
Quality of Life
Pain
Interventions
First Posted Date
2018-11-19
Last Posted Date
2018-11-19
Lead Sponsor
Near East University, Turkey
Target Recruit Count
60
Registration Number
NCT03745599
Locations
🇹🇷

Abdullah AlAlwani, Mersin, Turkey

© Copyright 2025. All Rights Reserved by MedPath